Skip to main content
Livermore
Livermore
ZHEN

MAI Capital Management

SEC CIK
0001040197
Latest filing
Aug 14, 2026

The latest 13F from MAI Capital Management covers Q2 2026 (filed Aug 14, 2026): 1,889 long positions worth $26.3B. The top 10 holdings make up 26.4% of the portfolio, and the largest is iShares Core S&P 500 ETF at 7.0%. Livermore has 22 filings on Form 13F from this institution, going back to Q1 2021.

What changed in Q2 2026

Share counts compared with Q1 2026: how many positions were new, added to, reduced or sold out, and the biggest buys and sells. Dollar amounts are estimated at the quarter-end prices implied by the filing.

Full comparison
New
55
Est. +$430.8M
Added
1501
Est. +$6.50B
Reduced
283
Est. −$124.6M
Sold out
2975
Est. −$110.8M

Top 5 holdings

Share of this quarter's portfolio value

  1. iShares Core S&P 500 ETF464287200
    7.0%$1.85B
  2. SPYSPDR S&P 500 ETF Trust
    3.4%$893.0MHistory
  3. AAPLApple Inc.
    3.3%$859.7MHistory
  4. GLDMWorld Gold Trust
    2.3%$595.4MHistory
  5. NVDANVIDIA Corp
    2.0%$519.4MHistory

Biggest buys

New and added positions, by estimated amount bought

  1. GLDMWorld Gold Trust
    +$593.9MAddedHistory
  2. iShares Core S&P 500 ETF464287200
    +$555.2MAdded
  3. Schwab US Tips ETF808524870
    +$305.5MAdded
  4. Vanguard Morningstar Total Stock Market ETF922908769
    +$247.3MAdded
  5. Flexshares Tr33939L407
    +$242.2MAdded

Largest weight increases

New and added positions, by percentage points of the portfolio gained

  1. GLDMWorld Gold Trust
    +2.26 pp<0.1% → 2.3%History
  2. Schwab US Tips ETF808524870
    +1.16 pp<0.1% → 1.2%
  3. Flexshares Tr33939L407
    +0.90 pp0.1% → 1.0%
  4. Tidal ETF Tr886364603
    +0.84 pp0.0% → 0.8%
  5. Vanguard Morningstar Total Stock Market ETF922908769
    +0.73 pp0.9% → 1.7%

Biggest sells

Reduced and sold-out positions, by estimated amount sold

  1. HONHoneywell International Inc
    −$39.9MSold outHistory
  2. iShares Tr464287440
    −$16.2MReduced
  3. First Tr Exchng Traded FD VI33740U711
    −$10.4MReduced
  4. EWEdwards Lifesciences Corp
    −$5.64MReducedHistory
  5. OWLBlue Owl Capital Inc.
    −$4.71MReducedHistory

Largest weight decreases

Reduced and sold-out positions, by percentage points of the portfolio lost

  1. JNJJohnson & Johnson
    −0.23 pp0.8% → 0.5%History
  2. HONHoneywell International Inc
    −0.23 pp0.2% → 0.0%History
  3. iShares Tr464287440
    −0.18 pp0.3% → 0.2%
  4. Pgim ETF Tr69344A107
    −0.14 pp0.4% → 0.3%
  5. Schwab US Dividend Equity ETF808524797
    −0.13 pp0.4% → 0.3%

Metrics

13F metrics for Q2 2026, computed only from the numbers in the filings. Definitions below.

Portfolio value
$26.3B
+$8.66B (+49.2%) vs. prior quarter
Positions
1,889
−2,920 vs. prior quarter
Top 10 concentration
26.4%
Top 10 as share of value
Turnover
1.1%
Q2 2026, one quarter
Average holding period
18.1 quarters
Weighted by value

How these are calculated

  • Portfolio value: the market value of all long positions in the 13F, as reported at quarter end, excluding options.
  • Top 10 concentration: the combined value of the 10 largest positions as a share of portfolio value.
  • Turnover: the smaller of this quarter's estimated purchases and estimated sales, divided by the average of this and last quarter's portfolio value. Estimates multiply the change in shares by the quarter-end price implied by the filing (market value divided by shares); new positions use this quarter's value and sold-out positions last quarter's. Only positions reported in shares count, and it is not calculated when the previous quarter was not filed.
  • Average holding period: how many consecutive quarters each current position has been held (including this one; a quarter without the position or without a filing starts the count over), weighted by this quarter's value. Counting starts with the first 13F in Livermore (Q1 2021), so positions held before then are understated.

13F filings by quarter

22 quarters, going back to Q1 2021. Bars show each quarter's 13F portfolio value; quarters without a filing are left blank.

Peak $26.3B (Q2 2026)

Q1 2021: $4.43BQ2 2021: $4.99BQ3 2021: $5.15BQ4 2021: $6.15BQ1 2022: $5.87BQ2 2022: $5.19BQ3 2022: $5.28BQ4 2022: $5.92BQ1 2023: $6.28BQ2 2023: $6.76BQ3 2023: $6.69BQ4 2023: $7.56BQ1 2024: $9.59BQ2 2024: $10.2BQ3 2024: $10.4BQ4 2024: $13.4BQ1 2025: $13.2BQ2 2025: $14.4BQ3 2025: $16.0BQ4 2025: $17.3BQ1 2026: $17.6BQ2 2026: $26.3B
Q1 2021Q2 2026
13F filings of MAI Capital Management by quarter
QuarterFiledPositionsValueTop 3 holdingsChangesFiling
Q2 2026Aug 14, 20261,889$26.3BiShares Core S&P 500 ETFSPYAAPLvs. Q1 2026SEC
Q1 2026May 15, 20264,809$17.6BiShares Core S&P 500 ETFAAPLSPYvs. Q4 2025SEC
Q4 2025Feb 13, 20264,149$17.3BiShares Core S&P 500 ETFSPYAAPLvs. Q3 2025SEC
Q3 2025Nov 10, 20253,604$16.0BiShares Core S&P 500 ETFSPYAAPLvs. Q2 2025SEC
Q2 2025Aug 12, 20253,775$14.4BiShares Core S&P 500 ETFSPYMSFTvs. Q1 2025SEC
Q1 2025May 15, 20253,265$13.2BiShares Core S&P 500 ETFSPYAAPLvs. Q4 2024SEC
Q4 2024Feb 14, 20253,325$13.4BiShares Core S&P 500 ETFAAPLSPYvs. Q3 2024SEC
Q3 2024Nov 7, 20241,101$10.4BiShares Core S&P 500 ETFSPYAAPLvs. Q2 2024SEC
Q2 2024Aug 12, 20241,262$10.2BiShares Core S&P 500 ETFMSFTSPYvs. Q1 2024SEC
Q1 2024May 8, 20241,225$9.59BiShares Core S&P 500 ETFSPYMSFTvs. Q4 2023SEC
Q4 2023Feb 9, 20241,120$7.56BiShares Core S&P 500 ETFMSFTSPYvs. Q3 2023SEC
Q3 2023Nov 14, 20231,073$6.69BiShares Core S&P 500 ETFAAPLSPYvs. Q2 2023SEC
Q2 2023Aug 2, 20231,077$6.76BiShares Core S&P 500 ETFAAPLMSFTvs. Q1 2023SEC
Q1 2023May 10, 20231,065$6.28BiShares Core S&P 500 ETFAAPLMSFTvs. Q4 2022SEC
Q4 2022Feb 9, 20231,027$5.92BiShares Core S&P 500 ETFSPYAAPLvs. Q3 2022SEC
Q3 2022Nov 15, 2022939$5.28BiShares Core S&P 500 ETFAAPLMSFTvs. Q2 2022SEC
Q2 2022Jul 19, 2022877$5.19BiShares Core S&P 500 ETFMSFTSPYvs. Q1 2022SEC
Q1 2022May 10, 2022902$5.87BiShares Core S&P 500 ETFAAPLMSFTvs. Q4 2021SEC
Q4 2021Feb 11, 2022905$6.15BiShares Core S&P 500 ETFAAPLMSFTvs. Q3 2021SEC
Q3 2021Nov 12, 2021800$5.15BiShares Core S&P 500 ETFMSFTSPYvs. Q2 2021SEC
Q2 2021Jul 19, 2021775$4.99BiShares Core S&P 500 ETFMSFTSPYvs. Q1 2021SEC
Q1 2021May 10, 2021710$4.43BiShares Core S&P 500 ETFSPYMSFT–SEC

13D and 13G filings

Companies where MAI Capital Management reports owning 5% or more on Schedule 13D or 13G, and its latest filings.

Current stakes of 5% or more

MAI Capital Management does not currently report owning 5% or more of any company.

Latest filings

3 filings on file made by MAI Capital Management or listing it as a reporting person, newest first.

Schedule 13D and 13G filings by MAI Capital Management
CompanyFiled (ET)FormStakeChangeEvent dateFiling
TRVITrevi Therapeutics, Inc.Jul 10, 20244:16 PM ET13G/A2.20%1.52M shares–Below 5%May 12, 2022SEC
PHASPhaseBio Pharmaceuticals IncJul 19, 202213G/AOld format–––SEC
TRVITrevi Therapeutics, Inc.Apr 8, 202213GOld format–New–SEC